Norris Medicines Limited (BOM:524414)
17.25
+0.17 (1.00%)
At close: Jul 7, 2025
Norris Medicines Company Description
Norris Medicines Limited primarily engages in the manufacture of pharmaceutical formulations in India.
It offers products in the fields of antibiotic, anti-inflammatory-pain management, analgesic, gastrointestinal, dermatological, nutrition, anti-malarial, anti-emetic, cough/cold, dental, diabetic, and cardiac, as well as other fields in various formulations, including tablets, capsules, liquid orals, and copical ointments.
The company also offers contract and loan license manufacturing services. In addition, it exports its products to European countries, Middle East, Far East, and African countries.
The company was incorporated in 1990 and is based in Ankleshwar, India.
Norris Medicines Limited
Country | India |
Founded | 1990 |
Industry | Pharmaceutical Preparations |
Employees | 45 |
CEO | Vimal Shah |
Contact Details
Address: Plot No. 801/P Ankleshwar, 393002 India | |
Phone | 91 26 4622 3462 |
Website | norrispharma.com |
Stock Details
Ticker Symbol | 524414 |
Exchange | Bombay Stock Exchange |
Fiscal Year | April - March |
Reporting Currency | INR |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Vimal Shah | Chief Executive Officer |
Iqubal Patel | Chief Financial Officer |
Bharat Shah | Chief Operating Officer |